Search research articles
Contact Us
Filters
Showing results (221-230 of 276) with videos related to
Page
of 28
Sort By:
Journal for Immunotherapy of Cancer
|
June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Journal of Crohn'S & Colitis
|
June 4, 2018
TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism
Felicia M Bloemendaal, Pim J Koelink, Karin A van Schie, et al.
Annals of the Rheumatic Diseases
|
July 30, 2024
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
Kristina Lend, Jon Lampa, Leonid Padyukov, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Alyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
The Journal of Rheumatology
|
July 17, 2015
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Chamaida Plasencia, Eva L Kneepkens, Gertjan Wolbink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2018
Adaptive antibody diversification through <i>N</i>-linked glycosylation of the immunoglobulin variable region
Fleur S van de Bovenkamp, Ninotska I L Derksen, Pleuni Ooijevaar-de Heer, et al.
Annals of Neurology
|
October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis
Zoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Arthritis Research & Therapy
|
September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
Sanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
Viruses
|
January 23, 2024
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
A Lianne Messchendorp, Jan-Stephan F Sanders, Alferso C Abrahams, et al.
Clinical & Translational Immunology
|
May 24, 2021
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska Il Derksen, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 276) with videos related to
Sort By:
Page
of 28
Journal for Immunotherapy of Cancer
|
June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Journal of Crohn'S & Colitis
|
June 4, 2018
TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism
Felicia M Bloemendaal, Pim J Koelink, Karin A van Schie, et al.
Annals of the Rheumatic Diseases
|
July 30, 2024
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
Kristina Lend, Jon Lampa, Leonid Padyukov, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Alyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
The Journal of Rheumatology
|
July 17, 2015
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity
Chamaida Plasencia, Eva L Kneepkens, Gertjan Wolbink, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2018
Adaptive antibody diversification through <i>N</i>-linked glycosylation of the immunoglobulin variable region
Fleur S van de Bovenkamp, Ninotska I L Derksen, Pleuni Ooijevaar-de Heer, et al.
Annals of Neurology
|
October 17, 2022
Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis
Zoé L E van Kempen, Laura Hogenboom, Alyssa A Toorop, et al.
Arthritis Research & Therapy
|
September 4, 2021
Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
Sanne Reijm, Theresa Kissel, Gerrie Stoeken-Rijsbergen, et al.
Viruses
|
January 23, 2024
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
A Lianne Messchendorp, Jan-Stephan F Sanders, Alferso C Abrahams, et al.
Clinical & Translational Immunology
|
May 24, 2021
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
Maurice Steenhuis, Gerard van Mierlo, Ninotska Il Derksen, et al.
Page
of 28